GP
Gaurav Pathak
Transitional Year Internship · Capital Health Regional Medical Center
Credentials: ·
History
Research
Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis
Review · Annals of Pharmacotherapy · 2024 · 36 citations
Clinical applications of exosomes in cosmetic dermatology
Review · Skin Health and Disease · 2024 · 24 citations
Vitiligo: From mechanisms of disease to treatable pathways
Review · Skin Health and Disease · 2024 · First of 5 authors · Corresponding · 18 citations
38 papers
11 papers · 8 as a resident
- SR
8 papers · 8 as a resident
8 papers
5 papers · 5 as a resident
- BS
4 papers
- RC
4 papers · 4 as a resident
3 papers · 1 as a resident
